Cargando…
Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement
Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953577/ https://www.ncbi.nlm.nih.gov/pubmed/36830963 http://dx.doi.org/10.3390/biomedicines11020425 |
_version_ | 1784893912234590208 |
---|---|
author | Świderek-Matysiak, Mariola Oset, Magdalena Domowicz, Małgorzata Galazka, Grażyna Namiecińska, Magdalena Stasiołek, Mariusz |
author_facet | Świderek-Matysiak, Mariola Oset, Magdalena Domowicz, Małgorzata Galazka, Grażyna Namiecińska, Magdalena Stasiołek, Mariusz |
author_sort | Świderek-Matysiak, Mariola |
collection | PubMed |
description | Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In total, 242 CSF samples were collected from patients undergoing differential MS diagnosis because of the presence of T2-hyperintensive lesions on brain MRI. The non-MS patients were subdivided into systemic inflammatory diseases with CNS involvement (SID) or cerebrovascular diseases (CVD) or other non-inflammatory diseases (NID). All samples were analyzed for the presence of oligoclonal bands and ELISA was performed for detection of: INF gamma, IL-6, neurofilaments light chain (NF-L), GFAP, CHI3L1, CXCL13, and osteopontin. Results: The level of IL-6 (p = 0.024), osteopontin (p = 0.0002), and NF-L (p = 0.002) was significantly different among groups. IL-6 (p = 0.0350) and NF-L (p = 0.0015) level was significantly higher in SID compared to NID patients. A significantly higher level of osteopontin (p = 0.00026) and NF-L (p = 0.002) in MS compared to NID population was noted. ROC analysis found weak diagnostic power for osteopontin and NFL-L. Conclusions: The classical and non-standard markers of inflammatory process and neurodegeneration do not allow for sufficient differentiation between MS and non-MS inflammatory CNS disorders. Weak diagnostic power observed for the osteopontin and NF-L needs to be further investigated. |
format | Online Article Text |
id | pubmed-9953577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99535772023-02-25 Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement Świderek-Matysiak, Mariola Oset, Magdalena Domowicz, Małgorzata Galazka, Grażyna Namiecińska, Magdalena Stasiołek, Mariusz Biomedicines Article Background: Diagnosis of multiple sclerosis (MS) is established on criteria according to clinical and radiological manifestation. Cerebrospinal fluid (CSF) analysis is an important part of differential diagnosis of MS and other inflammatory processes in the central nervous system (CNS). Methods: In total, 242 CSF samples were collected from patients undergoing differential MS diagnosis because of the presence of T2-hyperintensive lesions on brain MRI. The non-MS patients were subdivided into systemic inflammatory diseases with CNS involvement (SID) or cerebrovascular diseases (CVD) or other non-inflammatory diseases (NID). All samples were analyzed for the presence of oligoclonal bands and ELISA was performed for detection of: INF gamma, IL-6, neurofilaments light chain (NF-L), GFAP, CHI3L1, CXCL13, and osteopontin. Results: The level of IL-6 (p = 0.024), osteopontin (p = 0.0002), and NF-L (p = 0.002) was significantly different among groups. IL-6 (p = 0.0350) and NF-L (p = 0.0015) level was significantly higher in SID compared to NID patients. A significantly higher level of osteopontin (p = 0.00026) and NF-L (p = 0.002) in MS compared to NID population was noted. ROC analysis found weak diagnostic power for osteopontin and NFL-L. Conclusions: The classical and non-standard markers of inflammatory process and neurodegeneration do not allow for sufficient differentiation between MS and non-MS inflammatory CNS disorders. Weak diagnostic power observed for the osteopontin and NF-L needs to be further investigated. MDPI 2023-02-01 /pmc/articles/PMC9953577/ /pubmed/36830963 http://dx.doi.org/10.3390/biomedicines11020425 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Świderek-Matysiak, Mariola Oset, Magdalena Domowicz, Małgorzata Galazka, Grażyna Namiecińska, Magdalena Stasiołek, Mariusz Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
title | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
title_full | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
title_fullStr | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
title_full_unstemmed | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
title_short | Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement |
title_sort | cerebrospinal fluid biomarkers in differential diagnosis of multiple sclerosis and systemic inflammatory diseases with central nervous system involvement |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953577/ https://www.ncbi.nlm.nih.gov/pubmed/36830963 http://dx.doi.org/10.3390/biomedicines11020425 |
work_keys_str_mv | AT swiderekmatysiakmariola cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT osetmagdalena cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT domowiczmałgorzata cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT galazkagrazyna cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT namiecinskamagdalena cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement AT stasiołekmariusz cerebrospinalfluidbiomarkersindifferentialdiagnosisofmultiplesclerosisandsystemicinflammatorydiseaseswithcentralnervoussysteminvolvement |